Review




Structured Review

Biogen Inc cdp 323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdp 323/product/Biogen Inc
Average 90 stars, based on 1 article reviews
cdp 323 - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "Monoclonal antibody therapy in multiple sclerosis"

Article Title: Monoclonal antibody therapy in multiple sclerosis

Journal: mAbs

doi: 10.4161/mabs.2.6.13270

Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Figure Legend Snippet: Main industry-sponsored studies for oral NME currently in development for multiple sclerosis

Techniques Used:



Similar Products

90
Biogen Inc cdp 323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdp 323/product/Biogen Inc
Average 90 stars, based on 1 article reviews
cdp 323 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Adooq Bioscience LLC cdp-323 (zaurategrast)
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323 (Zaurategrast), supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdp-323 (zaurategrast)/product/Adooq Bioscience LLC
Average 90 stars, based on 1 article reviews
cdp-323 (zaurategrast) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biogen Inc dual 4 inhibitor cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Dual 4 Inhibitor Cdp 323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dual 4 inhibitor cdp-323/product/Biogen Inc
Average 90 stars, based on 1 article reviews
dual 4 inhibitor cdp-323 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biogen Inc cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdp-323/product/Biogen Inc
Average 90 stars, based on 1 article reviews
cdp-323 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Celltech Inc cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323, supplied by Celltech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdp-323/product/Celltech Inc
Average 90 stars, based on 1 article reviews
cdp-323 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Celltech Inc spirocyclic ethyl ester derivative 14 cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Spirocyclic Ethyl Ester Derivative 14 Cdp 323, supplied by Celltech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spirocyclic ethyl ester derivative 14 cdp-323/product/Celltech Inc
Average 90 stars, based on 1 article reviews
spirocyclic ethyl ester derivative 14 cdp-323 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Celltech Inc compound cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Compound Cdp 323, supplied by Celltech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compound cdp-323/product/Celltech Inc
Average 90 stars, based on 1 article reviews
compound cdp-323 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Main industry-sponsored studies for oral NME currently in development for multiple sclerosis

Journal: mAbs

Article Title: Monoclonal antibody therapy in multiple sclerosis

doi: 10.4161/mabs.2.6.13270

Figure Lengend Snippet: Main industry-sponsored studies for oral NME currently in development for multiple sclerosis

Article Snippet: CDP 323 , Phase 2 terminated , {"type":"clinical-trial","attrs":{"text":"NCT00484536","term_id":"NCT00484536"}} NCT00484536 , Biogen Idec UCB , p.o. , Integrin alpha4 antagonist , Placebo , RMS.

Techniques: